Ftse Mib
33.641,96
-0,28%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.909,84
6,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PainReform Ltd (PRFX) PainReform Ltd (PRFX) Notizie

PainReform Ltd

PRFX
0,8201
-0,0999 (-10,86%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:04:45
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202420:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/4/202414:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/4/202415:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02/4/202414:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
07/3/202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202422:34EDGAR2Form F-1 - Registration statement for certain foreign..
01/3/202414:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202414:00GLOBEPainReform Provides Year-End Business Update
29/2/202422:37EDGAR2Form 20-F - Annual and transition report of foreign private..
22/1/202414:30GLOBEPainReform to Present at the Microcap Conference in Atlantic..
22/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/1/202422:15EDGAR2Form F-3 - Registration statement by foreign private issuers
03/1/202414:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202414:30GLOBEPainReform Reports Successful Head-to-Head Comparison of..
27/12/202322:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202300:00GLOBEPainReform Announces Exercise of Warrants for Approximately..
15/11/202322:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202322:05GLOBEPainReform Provides Business Update for the Third Quarter of..
11/9/202314:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBEPainReform Announces Plans to Commence Second Part of Phase..
07/9/202316:00GLOBEPainReform Selected for Poster Presentation at the 13th..
05/9/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/9/202314:30GLOBEPainReform to Participate in the H.C. Wainwright 25th Annual..
25/8/202322:15EDGAR2Form F-1 - Registration statement for certain foreign..
10/8/202322:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202322:05GLOBEPainReform Provides Business Update for the Second Quarter..
19/7/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202315:00GLOBEPainReform Regains Compliance with Nasdaq Continued Listing..
18/7/202317:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202317:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202321:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202320:35GLOBEPainReform Announces Pricing of $1.5 Million Concurrent..
14/7/202318:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/7/202318:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202315:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202315:05GLOBEPainReform Announces Pricing of $2.7 Million Concurrent..
29/6/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/6/202314:30GLOBEPainReform to Present at the Maxim Group Virtual Healthcare..
07/6/202322:30GLOBEPainReform Provides Regulatory Update on Second Part of its..
18/5/202315:00GLOBEPainReform Announces Positive Pharmacokinetic (PK) Data in..
15/5/202322:45GLOBEPainReform Provides Business Update for the First Quarter of..
Apertura: 0,93 Min: 0,81 Max: 0,966
Chiusura: 0,92

La tua Cronologia

NASDAQ
PRFX
PainReform
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network